Research and development rebate due from australian government, net
-
-
-
0
Prepaid expenses and other current assets, net
75,973
104,977
118,036
30,639
Total current assets
373,779
721,304
143,622
49,723
Investment in oragenics, inc. common stock, at fair value
-
-
-
0
Total assets
373,779
721,304
143,622
49,723
Accounts payable and accrued wages
1,484,536
1,620,079
1,688,642
1,615,357
Accounts payable and accrued wages, officers
1,854,617
1,857,004
1,890,751
1,858,443
Accrued interest
586,351
509,348
395,775
421,440
Asset purchase liability
1,125,026
1,125,026
1,125,026
1,125,026
Convertible notes payable, officers and directors
-
-
100,000
-
Notes payable, net
-
-
394,222
-
Notes payable, officers and directors
100,000
100,000
-
100,000
Convertible notes payable, net
-
-
1,479,239
-
Notes payable, net of unamortized debt discounts
2,542,321
2,169,500
-
1,884,155
Derivative liability
2,430,585
3,936,166
225,155
-
Total current liabilities
10,123,436
11,317,123
7,298,810
7,004,421
Common stock, 0.001 par value, 500,000,000 shares authorized, 100,968,663 and 96,709,763 shares issued and outstanding as of april 30, 2026 and july 31, 2025, respectively
100,969
99,854
99,854
96,710
Additional paid-in capital
56,214,391
56,135,234
55,974,242
55,694,429
Accumulated deficit
-66,065,017
-66,830,907
-63,229,284
-62,745,837
Total stockholders' deficit
-9,749,657
-10,595,819
-7,155,188
-6,954,698
Total liabilities and stockholders' deficit
373,779
721,304
143,622
49,723
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.